Celeos will develop, certify and commercialise the SpiderMass technology to give surgeons an innovative medical device allowing them to obtain real-time and more precise information during tumour removal. It will help improve cancer care and lower the number of additional and unnecessary surgeries. We aim at becoming a reference tool in the hands of surgeons worldwide in the next years, bringing light for life.